ZBH vs ALGN — Key Metrics

Metric ZBH (ZIMMER BIOMET HOLDINGS INC) ALGN (ALIGN TECHNOLOGY INC)
Price103.32163.96
Market Cap19.55 Billion11.56 Billion
P/E (TTM)26.0323.83
P/B (Quarterly)1.6392.7
P/S (TTM)2.282.78
Net Profit Margin (TTM)9.011.8
Gross Margin (TTM)69.769.1
ROE (TTM)6.111.8
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

ZIMMER BIOMET HOLDINGS INC
vs
 
ALIGN TECHNOLOGY INC
 
ZIMMER BIOMET HOLDINGS INC
vs
 
ALIGN TECHNOLOGY INC
Performance Comparison
AI Model Recommendation
ZBH · ZIMMER BIOMET HOLDINGS INC

Underperform

-16
UnderperformOutperform
ALGN · ALIGN TECHNOLOGY INC

Outperform

52
UnderperformOutperform
Recommendation Summary

Stock ZBH is projected to underperform the market, stock ALGN is projected to outperform the market. Upfront Recommendation: ALGN.

Financial Metrics
Prices delayed ~15 min
ZBH Metrics ALGN
$103.32 Price $163.96
— Market Capitalization —
26.03 Price to Earnings Ratio 23.83
2.28 Price to Sales 2.78
15.1 Price to FCF Ratio 17.93
3.27 Price to Gross Profit 4.02
45.18 Price to R&D 30.61
3.81 Price to Current Assets 4.24

ZBH vs ALGN at a glance

Zimmer Biomet Holdings INC (ZBH) and Align Technology INC (ALGN) are both Medical Devices companies in the Healthcare sector. ZBH is the larger, at $19.6 billion in market value against $11.6 billion for ALGN, about 1.7 times the size.

On trailing-twelve-month figures, ZBH trades at 26.0 times trailing earnings and ALGN at 23.8; net profit margins are 9.0% and 11.8%.

The Upfront Investment model currently rates ZBH Underperform and ALGN Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.